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Rationale: Gas chromatography coupled to electron ionization mass spectrometry
(GC/EI-MS) is used for routine screening of anabolic steroids in many laboratories
after the conversion of polar groups into trimethylsilyl (TMS) derivatives. The aim of
this work is to elucidate the origin and formation of common and subclass-specific
fragments in the mass spectra of TMS-derivatized steroids. Especially in the context
of metabolite identification or analysis of designer drugs, isotopic labelling is helpful
to better understand fragment ion generation, identify unknown compounds and
update established screening methods.
Methods: Stable isotope labelling procedures for the introduction of [2H9]-TMS or
18O were established to generate perdeuterotrimethylsilylated, mixed deuterated and
18O-labelled derivatives for 13 different hydroxy steroids. Fragmentation proposals
were substantiated by comparison of the abundances of isotopically labelled and
unlabelled fragment ions in unit mass resolution GC/MS. Specific fragmentations
were also investigated by high-resolution MS (GC/quadrupole time-of-flight MS,
GC/QTOFMS).
Results: Methyl radical cleavage occurs primarily from the TMS groups in saturated
androstanes and from the steroid nucleus in the case of enol-TMS of oxo or
α,β-unsaturated steroid ketones. Loss of trimethylsilanol (TMSOH) is dependent on
steric factors, degree of saturation of the steroid backbone and the availability of a
hydrogen atom and TMSO group in the 1,3-diaxial position. For the formation of the
[M – 105]+ fragment ion, methyl radical cleavage predominates from the angular
methyl groups in position C-18 or C-19 and is independent of the site of TMSOH
loss. The common [M – 15 – 76]+ fragment ion was found in low abundance and
identified as [M – CH3 – (CH3)2SiH – OH]
+. For the different steroid subclasses
further diagnostic fragment ions were discussed and structure proposals postulated.
Conclusions: Stable isotope labelling of oxo groups as well as derivatization with
deuterated TMS groups enables the detection of structure-related fragment ion
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generation in unit mass resolution GC/EI-MS. This may in turn allow us to propose
isomeric assignments that are otherwise almost impossible using MS only.
1 | INTRODUCTION
Analytical challenges for the detection of the misuse of anabolic
agents are, for example, the administration of unapproved designer
drugs, the use of endogenous substances, and genetic polymorphisms
that lead to different metabolic patterns in the tested individual. In
addition, nutritional supplements contaminated with endogenous or
exogenous steroids are problematic since their intake can cause
inadvertent doping.1–3
Until the 1980s the fragmentation behavior of mostly
underivatized steroids was the subject of extensive and systematic
investigation4–6 but has not been the main focus of research since.
18O-labelling is not usually used for steroid research anymore but for
other fields, for example metabolomics or peptide mass
spectrometry.7,8
In times of MS-library searches for compound identification
stable isotopic labelling seems to be old fashioned and laborious.
However, when it comes to mass spectral interpretation, isotopic
labelling offers a suitable and practical way to trace back and
explain diagnostic fragment ions in spectra recorded by gas
chromatography/electron ionization mass spectrometry (GC/EI-MS)
with the respective mass shifts of +1 for deuterium and +2 m/z
units for oxygen-18. Misinterpretation of mass spectral data of
closely related substances with similar retention times and identical
molecular mass (e.g., the stereoisomers of 5ξ-androst-1-ene-3ξ,17ξ-
diol, androst-4-ene-3ξ,17ξ-diol and 17ξ-hydroxy-5ξ-androstan-
3-one9) may be reduced and characterization of specific structural
features facilitated. Especially in the context of designer drugs,
isotopic labelling is additionally helpful to better understand
fragment ion generation, identify unknown compounds and update
established screening methods.
For current GC/MS analyses, steroidal hydroxy and oxo
functions are often converted into trimethylsilyl (TMS) ether and
enol ether derivatives with trimethyliodosilane (TMIS, formed in
situ) reagent (N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA)/
ammonium iodide/ethanethiol, 1000:2:3, v/w/v).10,11 Through
silylation, steroid derivatives are more volatile and thermally stable
which enhances robust detection by GC/MS and this is the
preferred technique for screening of steroids, e.g., in doping
control samples. Derivatization greatly affects mass spectral
fragmentation12,13: TMS derivatives exhibit less fragmentation than
their underivatized analogs which increases the abundance of
diagnostic fragment ions. Many fragment ions contain one or
several TMS groups or are generated through their loss or
rearrangement.
Fragment ions explained by losses of TMS groups (e.g., loss of
trimethylsilanol (TMSOH) [M – 90]•+) as well as specific fragment ions
derived from the steroidal A-, B- or D-ring are described in the
literature.12, 14–18 However, many questions concerning the mass
spectra of TMS-derivatized steroids still remain unsolved and need to
be addressed.
Thus, the aim of this paper is to contribute possible explanations
for allegedly “unspecific” as well as more specific fragment ions in
GC/MS for different steroid subclasses. Starting from isotopic
labelling techniques for steroids established in the 1960s and 1970s,6,
19–23 more viable and faster approaches for the introduction of
deuterium and 18O were developed and optimized in the presented
work and their suitability shown for mass spectral fragmentation
analysis.
2 | EXPERIMENTAL
2.1 | Steroid standards
The reference standards 17β-hydroxy-5α-androstan-3-one
(5α-dihydrotestosterone, 5α-DHT, 7), 3α-hydroxy-5α-androstan-17-one
(androsterone, 8), 3β-hydroxyandrost-5-en-17-one (dehydroepian
drosterone, DHEA, 9), 17β-hydroxyandrost-4-en-3-one (testosterone,
10), 16,16,17-[2H3]-17β-hydroxy-androst-4-en-3-one (16,16,17-[2H3]-
testosterone, 11), 3α-hydroxy-5β-androstan-17-one (etiochalonolone, 14),
3β-hydroxy-5β-androstan-17-one (epietiochalonolone, 15), 3α-hydroxy-
5α-estran-17-one (19-norandrosterone, 12), and 17β-hydroxy-
19-norandrost-4-en-3-one (nandrolone, 13) were purchased from
Steraloids (Newport, RI, USA). 1α,2α-[2H2]-5α-Androstane-3α,17β-diol
(2.4.1), 2,2,3β,4,4-[2H5]-5α-androstane-3α,17β-diol (2.4.2), 1β,2β-[2H2]-
5α-DHT (7.4), and 2,2,3β,4,4-[2H5]-androsterone (8.4) were previously
synthesized in our group. 5α-Androstane-3β,17β-diol (1) was
synthesized from 7, 5α-androstane-3α,17β-diol (2) from 8, 5β-
androstane-3α,17β-diol (3) from 14, 5β-androstane-3β,17β-diol (4) from
15, androst-5-ene-3β,17β-diol (5) from 9, and androst-4-ene-3β,17β-diol
(6) from 10 via reduction with NaBH4 (see below).
2.2 | Reagents and chemicals
Water-18O (97 atom% 18O), ethanethiol (97%), 2-mercaptoethanol
(99%), sodium borohydride (NaBH4) and ammonium iodide (NH4I,
99.9%) were obtained from Sigma-Aldrich GmbH (Taufkirchen,
Germany). Toluene, diethyl ether, isopropylamine (99+%) and
titanium tetrachloride (TiCl4, 99.9%) were from Thermo Fisher
Scientific (Dreieich, Germany). N-Methyl-N-(trimethylsilyl)
trifluoroacetamide (MSTFA) was purchased from Chemische Fabrik
Karl Bucher GmbH (Waldstetten, Germany) and N,O-bis(trimethyl-
[2H9]-silyl)acetamide ([
2H18]-BSA) from Abcr GmbH (Karlsruhe,
Germany).
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2.3 | 18O-labelling procedure
Standards 7–10 and 14–15 (1.5 mg) were dissolved in 900 μL toluene
each. At a temperature of 0C, 18 μL TiCl4/toluene (1:2, v/v) and
45 μL isopropylamine were added while stirring. The mixture was
incubated at 100C for 15 min. After cooling, 900 μL water were
added to obtain two phases. After centrifugation for 5 min the upper
organic phase was used for further experiments. Aliquots of 30 μL
(toluene phase) and 60 μL of either H2O (control) or H218O were
evaporated at 100C in a heating block.
2.4 | Reduction of 3- or 17-oxo groups with
NaBH4
For the reduction of 3- or 17-oxo groups (to obtain standards 1–6),
the residue was dissolved in 1 mL diethyl ether. NaBH4 (2 mg) and
200 μL of water were added. After stirring at room temperature for
24 h, 1 mL of water was added. The extraction of the product was
performed using 3 × 1 mL diethyl ether. The organic layer was
evaporated at reduced pressure.
2.5 | Derivatization
Prior to GC/MS analyses, residues were derivatized with 90 μL
MSTFA/TMIS reagent (MSTFA/NH4I/ethanethiol, 1000:2:3, v/w/v) at
60C for 15 min. Standards 1–13 were additionally derivatized with
80 μL [2H18]-BSA/TMIS reagent (5 μL of a saturated NH4I solution in
2-mercaptoethanol added to 100 μL [2H18]-BSA) at 90C for 30 min
to achieve perdeuterotrimethylsilylation. Mixed deuterated
derivatives were prepared for standards 7–13. Residues were either
first derivatized with 15 μL of [2H18]-BSA, evaporated in a gentle
stream of nitrogen, and then treated with 65 μL MSTFA/TMIS
reagent, or the respective residue was first left to react with 15 μL
MSTFA, evaporated in a gentle stream of nitrogen, and subsequently
derivatized with 65 μL [2H18]-BSA/TMIS reagent.
2.6 | Instrumentation
Unit mass resolution GC/EI-MS analyses were performed on a model
7890 gas chromatograph (Agilent Technologies Inc., Santa Clara, CA,
USA) coupled to a model 5975C single quadrupole mass-selective
detector (Agilent Technologies) applying the following parameters:
column: Agilent HP-Ultra 1 (17 m × 200 μm × 0.11 μm), carrier gas:
helium, constant pressure: 1.14 bar, oven temperature program: 0 min
150C, +50C/min, 0 min 240C, +3C/min, 0 min 266C, +50C/min,
3 min 320C, injection volume: 2 μL, split 1:20, injection temperature:
300C, ionization: 70 eV, EI. For additional confirmation of some
fragment ions, high-resolution accurate mass spectrometry was
performed on an Agilent 7890 gas chromatograph coupled to an
Agilent 7200 QTOF mass spectrometer. The same column and the
same conditions as described before were used.
3 | RESULTS AND DISCUSSION
3.1 | Isotopic labelling
Investigation of fragmentations in steroid analysis was performed for
per-TMS-derivatized analytes. As is well known, the use of TMIS as
catalyst in combination with MSTFA results in the derivatization of
both hydroxy and oxo groups, the latter after enolization.24 To
achieve labelling of both steroidal hydroxy and oxo groups with [2H9]-
TMS, a labelled derivatization agent with enough silylation power was
needed. [2H9]-MSTFA was the reagent of choice for generation of the
catalyst [2H9]-TMIS and derivatization, but turned out to be
unsuitable for in-house synthesis due to very low yields. Vouros and
Harvey described a two-step procedure for the preparation of mixed
TMS and [2H9]-TMS derivatives of hydroxy steroids in 1973.
25 As
reagent they used N,N-bis(trimethylsilyl)trifluoroacetamide (BSTFA)
and trimethylsilylimidazole (TSIM) or [2H9]-TSIM. While unhindered
and hindered hydroxy groups were amenable for derivatization
therein, oxo groups were not silylated but separately derivatized to
methoximes. In our study, N,O-bis(trimethyl-[2H9]-silyl)acetamide
([2H18]-BSA) was found to be an effective alternative although the
silylation capacity of BSA is lower than that of MSTFA or BSTFA.26
For catalyst generation the addition of a saturated solution of
ammonium iodide in 2-mercaptoethanol delivered the best results.
Using this combination isotopic labelling was performed
straightforwardly by introduction of perdeuterotrimethylsilyl
([2H9]-TMS) groups on both the hydroxy and the oxo groups.
Inspired by the observation that 3-oxo steroids form imine
derivatives that are easy to hydrolyse with tris(hydroxymethyl)
aminomethane during work up of biological samples,27 a method was
developed to use imine intermediates for 18O-labelling. For this
purpose, isopropyl amine was used and cleaved off again with H2
18O,
yielding the original steroid with 18O-oxo groups (Figure 1). This fast
and targeted method has also successfully been used in our group for
other compounds such as benzophenone derivatives.28 In contrast to
an earlier described method for 18O-labelling of steroids by Lawson
et al in 19696 as an acid-catalyzed exchange reaction of carbonyl
groups with H2
18O, this procedure allows fast and reproducible
F IGURE 1 Procedure used
for 18O-labelling of steroids
exemplified by androsterone (8,
educt) and 5α-androstane-
3α,17β-bis-TMS (2, product)
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oxygen exchange, while the acid catalysis method showed a strong
dependence of exchange rates on the temperature and steric
environment of the carbonyl group. Using acid-catalyzed labelling for
4-ene-3-ones such as testosterone, for example, a reaction time of
72 h was needed until the desired equilibrium was achieved, while the
exchange procedure described herein only required less than 2 h. To
obtain 18O-labelled hydroxy groups, the labelled oxo steroids were
reduced with NaBH4 (Figure 1).
3.2 | Mass spectral fragmentation analyses
Methyl radical cleavage ([M – CH3]
+, [M – 15]+), neutral loss of
trimethylsilanol ([M – TMSOH]•+, [M – 90]•+) and their concerted or
sequential loss ([M – TMSOH – CH3]
+, [M – 105]+) are common
features in GC/MS spectra of trimethylsilylated hydroxy steroids.
Generally, these losses are considered to be rather unspecific and an
explanation of their exact formation and their origin is rarely given.
These three examples together with the
[M – CH3 – (CH3)2SiH – OH]
+, ([M – 91]+) ion and other diagnostic
GC/MS fragment ions used for the comparison of different androgen
subclasses are discussed below. Regio- and stereoselectivity were
elucidated from the relative abundances of the respective isotopically
labelled and unlabelled fragment ions. The percentage of contribution
of the individual isotopologous fragment ions was calculated as a
proportion of the total abundance of the respective fragment ion
(Tables 1 and 2). Based on these findings, explanations for fragment
ion generation are proposed.
3.3 | Fragment ion [M – CH3]
+
Methyl radical cleavage from a TMS-derivatized steroid can originate
from either one of the TMS groups or one of the angular methyl
groups C-18 or C-19 of the steroid nucleus. In the mass spectra of all
perdeuterotrimethylsilylated steroids 1–13 both [M – CH3]
+ and
[M – CD3]
+ ions are observed with different abundance ratios
(fragments #.3B, Tables 1 and 2).
In the mass spectra of the fully saturated androstanes 1–4 methyl
radical cleavage primarily takes place from the TMS groups (Figure 2;
2.3B: [M – CD3]
+ = m/z 436.4 and 1.3B, Table 1). In 5α-androstane-
3β,17β-diol (1), for example, the [M – CD3]+ = m/z 436.4 ion
contributes 90% and the [M – CH3]
+ = m/z 439.4 ion 10% to the
overall abundance (2.3B, Table 1). In case of the enol-TMS steroids
8–13 on the other hand, methyl radical loss originates predominantly
from the steroid nucleus. Fragment ion [M – CD3]
+ contributes less
than 5% in the 3,17-bis-[2H9]-TMS and the respective mixed
deuterated spectra of androsterone (8.3B, 8.5B, 8.6B, Table 2) and
DHEA (9, Figure 3: m/z 432.4 (9.3), m/z 423.3 (9.5, 9.6) and Table 2:
9.3B, 9.5B, 9.6B). In the mass spectra of perdeuterotrimethylsilylated
testosterone (10.3B, Table 2) and 16,16,17-[2H3]-testosterone (11.3B,
Table 2) derivatives, less than 15% of the [M – CD3]
+ ion is observed
and less than 8% for the mixed deuterated derivatives (10.5B, 10.6B,
11.5B, 11.6B, Table 2). Earlier findings about the position of methyl
cleavage in Δ4 steroids from Harvey and Vouros29 can thus be
confirmed.
Compared with its saturated counterparts 1 to 4, the double
bond in androst-4-ene-3β,17β-diol (6) directs methyl radical cleavage
to the steroid nucleus with the [M – CD3]
+ ion observed with 23%
relative abundance only (6.3B, Table 1). In androst-5-ene-3β,17β-diol
(5) this cleavage is less dominant as the 5-ene isomer exhibits the ion
[M – CD3]
+ with 55%, which indicates that the [M – CD3]
+ and
[M – CH3]
+ ions are produced with similar abundances (5.3B, Table 1).
Interestingly, in the 5-ene-17-oxo steroid DHEA (9) 95% of the
methyl loss originates from the steroid nucleus (observed as
[M – CH3]
+), i.e. [M – CD3]
+ represents only 5% (9.3B, Table 2).
In 5α-DHT (7) the mass spectrum of the 3,17-bis-[2H9]-TMS
derivative exhibits both [M – CD3]
+ and [M – CH3]
+ in a ratio of
approximately 50:50 (7.3B, Table 2). The ratio is shifted to 84% for
[M – CD3]
+ in the mass spectrum of the 3-[2H9]-TMS,17-TMS
derivative (7.5B, Table 2) and to 5% in the spectrum of the
3-TMS,17-[2H9]-TMS derivative (7.6B, Table 2). Thus, the methyl loss
originates from either the steroid nucleus or the TMS-enol group in
position C-3.
3.4 | Fragment ion [M – TMSOH]•+
In 1972, Vouros and Harvey investigated the site of TMSOH
elimination in a number of di- and trihydroxysteroids21 and found that
it is, in fact, not a random process but highly dependent on the steric
environment of the respective silylated hydroxy group. Depending on
the structure of the precursor for the 18O-labelling procedure, the
oxygen of the TMSO group was labelled either in position C-3
(steroids 1, 6–7 and 10, #.2, Table 3) or in position C-17 (steroids 2–5,
8 and 9, #.2, Table 3).
According to the literature, the 5α-androstanediols 1 and
2 preferably cleave off TMSOH from the C-17 position and, if from
the A-ring, more easily from the 3α than from the 3β position.21
18O-labelling in position C-3 for 1 and position C-17 for 2 shows that
23% (m/z 346.3) of TMSOH loss originates from C-3 in 1 (3β, 1.2C,
Table 1) and 39% (m/z 348.3) in 2 (3α, 2.2C, Table 1).
For 5α-androstane-3α,17β-bis-TMS (2.1C, Table 1), the
hydrogens in positions 1α and 5α are suitable for elimination together
with the TMS oxygen (2.1, Table 3) due to their preferred 1,3-diaxial
position.30 Mass spectra of the 2,2,3β, 4,4-[2H5] derivative of
2 (2.4.2C, Table 1) show that almost all the attached deuterium atoms
were retained in ring A after TMSOH loss. Fragment ion [M – 90]+
(m/z 351.3) makes up 86% of the signal and [M – 91]+ only 14%
(Figure 2, 2.4.2). If position 1α is deuterated, however, the [M – 91]+
ion contributes 41% (2.4.1D, Table 1; Figure 2, 2.4.1). In the case of
1 (the 3β isomer) the 1β hydrogen is the only one available for
TMSOH formation and even this is only possible from the unfavored
boat conformation (1.1, Table 3). This may explain why the 3α isomer
(2) results in higher abundance of TMSOH elimination from the
A-ring: compared with the respective base peaks in the 18O-labelled
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mass spectra, the m/z 346.3 fragment ion of 1 (1.2C) has 3% and the
m/z 348.3 ion (2.2C, Table 1) 8% relative abundance. If TMSOH
elimination occurs in the D-ring, the hydrogen in position 15β and the
three hydrogens from the C-18 methyl group are within bonding
distance of the OTMS oxygen (1.1, Table 3).
The 5β-androstanediols 3 and 4 cleave off TMSOH mainly from
the A-ring with the same preference for the 3α position as the 5α-
androstanediols. In the mass spectra of the 18O-labelled derivatives
[M – 90]•+ = m/z 348.3 is observed for 3α (3.2C) with 90% and for 3β
(4.2C, Table 1) with 80%. Suitable hydrogens for the neutral loss of
trimethylsilanol are at positions 7α and 9α for 5β-androstane-3α,17β-
bis-TMS (3.1, Table 3), if the A-ring is in the boat conformation and
the TMSO group is located beneath the steroid backbone. In the case
of 5β-androstane-3β,17β-bis-TMS (4) the hydrogens in positions 1β
and 5β are at the right distance for elimination with TMSO from the
A-ring (4.1, Table 3). Further confirmation will be addressed in future
investigations.
If a double bond in position Δ5 is present in the steroid nucleus
as in androst-5-ene-3β,17β-diol (5), the [M – 90]•+ fragment ion
originates from the A-ring.25, 31–33 After labelling of the C-17 oxygen,
the mass spectrum shows 87% TMSOH loss from 3β ([M – 90]•+) and
13% from 17β ([M – 92]•+, 5.2C, Table 1). This result can be explained
by the stability of the resulting [M – 90]•+ ion in which a double bond
is formed in conjugation to the Δ5 double bond.21 If the A-ring is in
the boat conformation, the bonding distance between the TMS-
oxygen and the 1β hydrogen is reduced, making loss of TMSOH more
likely (5.1, Table 3).
The Δ4 double bond of androst-4-ene-3β,17β-diol (6) also tends
to direct TMSOH elimination to the A-ring. 18O-labelling substantiates
preferred TMSOH loss from position 3β (84% [M – 92]•+ and 16%
[M – 90]•+, 6.2C, Table 1). Pseudo-boat formation in ring A for bonding
of TMSO with the 1β hydrogen is possible (6.1, Table 3). According to
the literature, cleavage of the C-2/C-3 bond with subsequent TMSO
loss is facilitated by the Δ4 double bond.29 After bond cleavage and
free rotation of the C-4/C-5 bond, the 3β-TMSO is also within bonding
distance of the C-6 hydrogens.
In general, the TMS enol derivatives 7–13 produce [M – 90]•+
and [M – 105]+ (see below) fragment ions with a much lower
abundance than the diols. Due to enolization, the TMS group is
attached to a sp2 carbon and this together with the neighbouring
double bond makes the steroid backbone more rigid (for example, in
testosterone, 10.1, Table 3). Suitable hydrogens for TMSOH loss are
out of the required bonding distance of 3.2 Å.30 Thus, TMSOH
elimination predominates from the unlabelled TMS ether function if a
TMS ether and a (18O-labelled) TMS enol are present (standards 7–
10): In the case of androsterone (8), for example, 86% of the TMSOH
loss originates from ring A ([M – 90]•+ = m/z 346.3) and only 14%
from ring D ([M – 92]•+ = m/z 344.4, 8.2C, Table 2). The same applies
to fragment ions [M – 105]+ = m/z 331.3 (93%) and
[M – CH3 – TMS
18OH]+ = [M – 107]+ (7%, 8.2E, Table 2). In the mass
spectrum of DHEA (9) the [M – 105]+ = m/z 329.2 ion (9.2E, Table 2;
9.2, Figure 3) also mainly originates from the A-ring and in 5α-DHT (7,
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Testosterone (10) and 16,16,17-[2H3]-testosterone (11) cleave off
TMSOH (m/z 351.3 (94%, 10.5C) and m/z 354.3 (93%, 11.5C, Table 2)
when the C-3 TMS enol ether is labelled and [2H9]-TMSOH (m/z
342.2 (92%, 10.6C) and m/z 345.3 (92%, 11.6C, Table 2) when the C-
17 TMS ether is labelled with deuterium, confirming the dominant
elimination from the D-ring. No deuterium from C-16 or C-17 is lost
with this elimination in the case of the 16,16,17-[2H3]-labelled
derivative 11 (see below). 18O-labelling of the A-ring of testosterone
(10) supplies further evidence for the preferred loss of TMSOH from
C-17: the [M – 90]•+ = m/z 344.3 fragment ion is observed with 82%
and [M – 92]•+ = m/z 342.3 with 18% in the respective mass
spectrum (10.2C, Table 2).
3.5 | Fragment ion [M – CH3 – TMSOH]
+
Aberrant from the above mentioned, the
[M – CH3 – TMSOH]
+ = [M – 105]+ ion is primarily shifted to
[M – CH3 – [
2H9]-TMSOH]
+ = [M – 114]+ in the perdeutero
trimethylsilylated spectra of all standards (#.3E, Tables 1 and 2). Even
if, for example, in the spectra of the androstanediols 1–4 [M – CD3]
+
(m/z 436.4) is more abundant than [M – CH3]
+ (m/z 439.5), the
[M – CD3 – [
2H9]-TMSOH]
+ = [M – 117]+ ion (m/z 337.3, 1.3E, 2.3E,
4.3E, Table 1) is observed with very low abundance (2, Figure 2, 2.3);
it represents less than 15%, except for 3 (41%, 3.3E, Table 1). In the
course of future studies, androstanediol derivatives doubly labelled
with 18O and [2H9]-TMS may be synthesized. If a [M – 119]
+ fragment
ion is observed for 5β-androstane-3α-18O,3α,17β-bis-[2H9]-TMS (3), for
example, the cleaved [2H9]-TMSOH group must originate from the
A-ring. Overall, the findings shown in Table 1, however, indicate
that for the formation of the [M – 105]+/[M – 114]+ fragment ion the
required methyl radical cleavage predominates from one of the
angular methyl groups in position C-18 or C-19 and not from the TMS
methyl groups.
The mixed 3-[2H9]-TMS,17-TMS derivatives of 5α-DHT (7.5),
testosterone (10.5) and 16,16,17-[2H3]-testosterone (11.5, Table 3)
also produce a [M – CD3 – TMSOH]
+ = [M – 108]+ fragment ion with
relative abundances of 15%, 4% and 5%, respectively, compared with
[M – 105]+ (not included in Table 1). In these cases, a CD3 radical
from the [2H9]-TMS enol group at position C-3 is cleaved off together
with the TMSOH group from position C-17. In the mass spectra of
the two partially deuterated DHEA derivatives (9.5E, 9.6E, Table 1),
neither the [M – 117]+ nor the [M – 108]+ fragment ion is detected,
probably due to the low abundance of the [M – CD3]
+ ion (Figure 3,
9.5, 9.6).
The spectra of the mixed deuterated derivatives of 5α-DHT
(7.5, 7.6), DHEA (9.5, 9.6), testosterone (10.5, 10.6), and
16,16,17-[2H3]-testosterone (11.5, 11.6, Table 3) substantiate the
cleavage of ●CH3-TMSOH ([M – 105]
+ or [M – 114]+) from the
respective TMS ether and not the enol ether group. For example, if
the [2H9]-TMS group is attached to the A-ring (e.g., in the case for the
3-[2H9]-TMS,17-TMS derivatives of DHEA (9)) the [M – 114]
+ ion is



















































































































































































































































































































































































































KOLLMEIER AND PARR 11 of 21
Figure 3, 9.5). If, however, the TMS group in position C-17 is labelled
(3-TMS,17-[2H9]-TMS derivative of DHEA, 9.6E, Table 2), the
[M – 105]+ ion is primarily formed (Figure 3, 9.6: m/z 336.3).
In the mass spectra of the 18O-labelled steroids 1–9 the
[M – CH3 – TMS
18OH]+ = [M – 107]+ ion can be observed in addition
to [M – 105]+, indicating that there are several routes of formation. In
the case of steroids 4–7 the [M – 107]+ ion is generated with
approximately the same ratio as [M – 92]•+ ([M – TMS18OH]•+); for
example, m/z 329.2 (36%, 7.2E) and m/z 344.2 (37%, 7.2C, Table 2)
for 5α-DHT (7). The 18O-labelled TMS derivatives of androsterone (8)
and DHEA (9) predominantly cleave off TMSOH from the unlabelled
A-ring to form the [M – 105]+ ion. The [M – 107]+ fragment ion is
detected with 7% relative abundance (m/z 329.2 for androsterone,
8.2E) and 13% (m/z 327.2 for DHEA, 9.2E), which is half the relative
abundance for the respective [M – 92]•+ ions (8.2C, 9.2C, Table 2).
For the androstanediols 1–3 no clear correlation between these
fragment ions can be made (Figure 2, 2.2). Overall, these findings
show that the [M – 90]•+ and [M – 105]+ fragment ions (plus
[M – 92]•+ and [M – 107]+ for the 18O-labelled derivatives) are
generated independently from each other and can originate from
different TMS groups within the steroid backbone.
Comparisons of the mass spectra of androsterone (8) and
testosterone (10) with their respective 19-nor analogs (12, 13) show
that the [M – 105]+ and [M – 114]+ fragment ions (for the
perdeuterotrimethylsilylated derivatives) are generated with similar
ratios (for mass spectra, see supporting information). The [M – 15]+
ion (m/z 419.2, 8.1B) is the base peak in the mass spectrum of
androsterone (8), and the abundance of the [M – 105]+ (m/z 329.2,
8.1E, Table 2) fragment ion is 62% of the base peak. In the case of the
19-norandrosterone (12.1B) spectrum the abundance of the
[M – 105]+ (m/z 315.1, 12.1E) ion is 51% of the base peak [M – 15]+
(m/z 405.3, 12.1B, Table 2). The fragment ion [M – 15]+ is also the
base peak in the mass spectrum of perdeuterotrimethylsilylated
19-norandrosterone (12), where [M – 18]+ is observed with only 5%
F IGURE 2 GC/MS spectra of 5α-androstane-3α,17β-diol (2) as bis-d0-TMS (2.1), 17β-18O-bis-TMS (2.2), 3,17-bis-[2H9]-TMS (2.3),
1α,2α-[2H2]-bis-TMS (2.4.1) and 2,2,3β,4,4-[2H5]-bis-TMS (2.4.2) derivatives
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(12.3B, Table 2) of the overall abundance. These findings suggest that
the methyl group cleaved off for the generation of the [M – 15]+ and
[M – 105]+/[M – 114]+ ions is derived from the C-18 group in
19-norandrosterone (12) and thus probably also in androsterone (8).
Similarly, the [M – CD3 – [
2H9]-TMSOH]
+ = [M – 117]+ fragment ion
is observed with 5% relative abundance in the spectra of
perdeuterotrimethylsilylated testosterone (m/z 333.3, 10.3E) and
19-nortestosterone (m/z 319.2, 13.3E, Table 2), suggesting that the
[M – CH3 – [
2H9]-TMSOH]
+ = [M – 114]+ fragment ion is also
predominantly formed for both steroids by loss of the C-18 methyl
group. However, when comparing the abundances of the [M – CD3]
+
fragment ion, the 3,17-bis-[2H9]-TMS derivative of
19-nortestosterone (13.3, Table 3) generates approximately twice as
much (34%, 13.3B) as the respective testosterone derivative (15%,
10.3B, Table 2). Overall, loss of a methyl radical predominates from
the steroid nucleus even if only one angular methyl group is present.
3.6 | Fragment ion [M – CH3 – (CH3)2SiH-OH]
+
Undervalued as a fragment ion until now, in all the analyzed mass spectra
of unlabelled steroids a [M – 91]+ ion is observed next to the
[M – 90]+.ion. In the mass spectra of steroids 7 and 8, the [M – 91]+
fragment ion (7.1D, 8.1D) is even more abundant than the [M – 90]+. ion
(7.1C, 8.1C, Table 2). This fragment ion may be explained by loss of a
methyl radical from a TMS function followed by neutral loss of the
remaining dimethylsilyloxy group plus two additional hydrogen atoms
from the steroid backbone ((CH3)2-SiH-OH, exact mass 76.0344). The ion
can thus be described as [M – CH3 – (CH3)2SiH-OH]
+ = [M – 15 – 76]+.
If the respective TMS group is deuterated, the observed loss is shifted to
[M – CD3 – (CD3)2SiH-OH]
+ = [M – 18 – 82]+ (7.3D, 8.3D, Table 2).
GC/QTOF accurate mass measurement of the [2H9]-TMS-labelled
testosterone derivatives provides ions at m/z 350.2851 (10.3D),
350.2867 (10.5D) and 341.2289 (10.6D, Tables 2 and 4), which are
in accordance with the proposed fragment ion generation pathway
(for mass spectra, see supporting information).
In the case of the 18O-labelled derivatives, formation of both
[M – 91]+ (10.2D) and [M – 93]+ = [M – CH3 – (CH3)2-SiH-
18OH]+
ions is observed, showing that there is no preferred cleavage site
(from C-3 or C-17). For steroids 1–2, 5–8 and 12 an additional
[M – 181]+ fragment ion is detected, corresponding to losses of
TMSOH together with CH3-(CH3)2SiH-OH (#.1G, Tables 1 and 2). In
the mass spectrum of 16,16,17-[2H3]-testosterone (11), there are two
possible explanations for the loss of 91 Da: either loss of TMSOD
(instead of TMSOH) from the D-ring or cleavage of CH3–(CH3)2SiH-
OH. In the QTOF spectrum an ion at m/z 344.2472 is observed
(11.1D, Tables 2 and 4). If TMSOD is cleaved off, the theoretical exact
mass of the resulting fragment ion C22H32D2OSi
+ is m/z 344.2499,
with an experimental mass error of 7.8 ppm. With a mass
measurement error of only 3.2 ppm, formation of the C22H30D3OSi
+
(11.1D, Table 4) ion is thus more likely. The accurate masses of the
[2H9]-TMS derivatives also comply with this finding (11.3D, 11.5D,
F IGURE 3 GC/MS spectra of DHEA (9) as bis-d0-TMS (9.1), 17β-18O-bis-TMS (9.2), 3,17-bis-[2H9]-TMS (9.3), 3-[2H9]-TMS,17-TMS (9.5), and
3-TMS,17-[2H9]-TMS (9.6) derivatives
KOLLMEIER AND PARR 13 of 21
11.6D, Table 4). Because the mass errors of the differently labelled
derivatives are lower for the [M – 15 – 76]+ ion than for the
[M – TMSOD]+ ion and 16,16,17-[2H3]-testosterone produces in total
only 6% more of the [M – 91]+ ion than testosterone, the required
hydrogen for TMSOH loss from the D-ring probably originates from
somewhere other than positions C-16 and C-17. A [M – 15 – 77]+
(11.1D, Table 2) ion is additionally observed in low abundance in the
mass spectrum of 16,16,17-[2H3]-testosterone and corresponds to
[M – CH3-(CH3)2SiD – OH]
+.
3.7 | Fragment ions representing structural
specificity
3.7.1 | m/z 129 and [M – 129]+
In all four diastereomeric androstanediols 1–4, (2.1, Figure 2) m/z
129.1 represents the base peak and is found to originate from the
D-ring (84–88% in the 18O-labelled mass spectra, #.2I, Table 1).
According to the literature, this fragment ion is indicative of
TMS- derivatized 3- or 17-hydroxy functions of steroids from A- or
D-ring cleavage, respectively.16, 19, 22 When the 3β-oxygen in
5α-androstane-3β,17β-diol (1) is exchanged with 18O, almost no mass
shift is observed (84% m/z 129.1, 1.2I, Table 1), while the ion is mainly
shifted to m/z 131.1 in the 17β-oxygen-labelled derivatives 2–4 (2.2,
Figure 2). In the mass spectrum of the 2,2,3β,4,4-[2H5] derivative of
5α-androstane-3α,17β-diol (2) the m/z 129.1 ion is not shifted (2.4I,
Table 1; 2.4.2, Figure 2). This substantiates generation of this
fragment ion from somewhere other than the A-ring. These findings
comply with an earlier study from Middleditch,34 stating that 85% of
the m/z 129 ions from 2 originate from the D-ring. In the case of
androst-4-ene-3β,17β (6) the m/z 129.1 ion has a low abundance and
also originates from the D-ring, as no mass shift is observed when the
C-3 oxygen is labelled.
If the D-ring is labelled with 18O, no mass shift is detectable for
the m/z 129.1 fragment ion in the mass spectrum of DHEA (9.2I,
Table 2; 9.2, Figure 3). In contrast, in the mass spectrum of
androst-5-ene-3β,17β-diol (5.2I, Table 1) 72% relative abundance
m/z 129.1 and 28% relative abundance m/z 131.1 can be observed
in the case of 18O-labelling in the D-ring, indicating that this ion
originates predominantly from the A-ring but is also formed from
the D-ring. In the mass spectra of 3β-trimethylsilyloxy Δ5-steroids
such as DHEA (9) and androst-5-ene-3β,17β-diol (5) [M – 129]+ ions
are observed in addition to the m/z 129 ion.19, 34, 35 In DHEA the
[M – 129]+ fragment ion is detected at m/z 303.1 (9.1J, Table 2;
9.1, Figure 3). It is shifted to m/z 305.2 in the spectrum after 18O
labelling (9.2J, Table 2; 9.2 Figure 3), to m/z 312.3 for the
3,17-bis-[2H9]-TMS (9.3J, Table 2, 9.3 Figure 3) and the 3-TMS,
17-[2H9]-TMS (9.6J, Table 2, 9.6, Figure 3) derivatives. These
findings comply with the assumption that this fragment ion is
formed from the remainder of the molecule including the D-ring
after the m/z 129 ion is cleaved off from the A-ring. To a minor
extent the [M – 129]+ fragment ion can also represent the A-ring as
18O-labelling data of 5 shows the m/z 307.2 ([M – 129]+, D-ring
still present) ion with 84% relative abundance, while the m/z 305.2
([M – 131]+, A-ring still present) ion represents 16% of the overall
abundance (5.2J, Table 1).
3.7.2 | m/z 127
The m/z 127.1 fragment ion is only found in the mass spectrum of 5α-
DHT (7). Because it is shifted to m/z 129.1 in the spectrum of the
18O-labelled, to m/z 129.1 (7.2L, 62%) and m/z 128.1 (7.4L, 38%, loss
of one deuterium atom) for the 1β,2β-[2H2] and to m/z 136.1 for the
3-[2H9]TMS, 17-TMS (7.5L, Table 2) derivatives, it is proposed to
originate from the A-ring and might be analogous to the m/z 129 ion
with an additional double bond. GC/QTOF data supports the
proposed elemental composition of C6H11OSi
+ for this ion (7.1L–7.6L,
Table 4).
3.7.3 | m/z 143
The fragment ion at m/z 143.1 in the mass spectrum of androst-
4-ene-3β,17β-diol (6) is attributed to the A-ring. It is shifted to m/z
145.1 (6.2K) after 18O-labelling of the oxygen at C-3 and to m/z 152.1
(6.3K, Table 1) in the mass spectrum of the
perdeuterotrimethylsilylated derivative. This ion is usually described
in the literature as a marker for 17α-alkylated synthetic steroids16 but
it also occurs in the mass spectra of 3-keto-enol steroid derivatives
such as 5α-DHT or 3-hydroxyandrost-1- or -4-ene steroids.9 m/z 143 is
described as a resonance-stabilized 3-(O-trimethylsilyl)but-1-ene ion
with the elemental composition C7H15OSi
+.36 The exact formation of
this ion in this case still needs to be determined but the double bond in
ring A seems to play an important role.
As mentioned above, m/z 143.1 may also originate from the
A-ring in the mass spectrum of 5α-DHT (7.1K). It is shifted to m/z
152.1 (7.5K) when [2H9]-TMS is attached to position C-3 but no
mass shift is observed when the C-17 TMS group is deuterated
(7.6K, Tables 2 and 4). In the case of the 1β,2β-[2H2] derivative
(7.4K, Table 2), two fragment ions, m/z 144.2 (51%) and 145.2
(49%), are observed, which implies the involvement of either one or
two hydrogens from these positions in the A-ring. These results
confirm the conclusion of Borges et al36 that the m/z 143 ion for
5α-DHT must be generated from somewhere other than the D-ring
because there was no mass shift in the spectrum of the silylated
16,16,17-[2H3] derivative.
3.7.4 | m/z 169
A typical fragment ion seen in the mass spectra of androsterone (8)
and DHEA (9) is m/z 169.1 which was previously described as a
marker for 17-oxo steroids.16, 37 It is shifted to m/z 171.1 for the
18O-labelled derivatives (8.2M, 9.2M) and to m/z 178.2 for the
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3,17-bis[2H9]-TMS derivatives (8.3M, 9.3M, Table 2; 9.1–9.3,
Figure 3). It is derived from cleavage in the C-ring and contains the
angular methyl group in position C-18 (meaning that C-13–C-18 are
present in the C9H17OSi
+ ion, 9.1, Table 3). In the case of the two
mixed deuterated derivatives of DHEA (9), m/z 169.1 (9.5 M) is
detected when only the A-ring is labelled with [2H9]-TMS, and m/z



























































TABLE 4 GC/QTOFMS data of specific fragment ions of
standards 5α-DHT (7), testosterone (10), 16,16,17-[2H3]-testosterone









+ 143.0892 143.0887 3.5 ppm
7.3K C6H6D9OSi
+ 152.1460 152.1452 5.3 ppm
7.5K C6H6D9OSi
+ 152.1450 152.1452 1.3 ppm
7.6K C7H15OSi
+ 143.0886 143.0887 0.7 ppm
7.1L C6H11OSi
+ 127.0579 127.0574 3.9 ppm
7.3L C6H2D9OSi
+ 136.1140 136.1139 0.7 ppm
7.5L C6H2D9OSi
+ 136.1145 136.1139 4.4 ppm
7.6L C6H11OSi
+ 127.0576 127.0574 1.6 ppm
10.1D C22H33OSi
+ 341.2288 341.2295 2.0 ppm
10.3D C22H24D9OSi
+ 350.2851 350.2860 2.6 ppm
10.5D C22H24D9OSi
+ 350.2867 350.2860 2.0 ppm
10.6D C22H33OSi
+ 341.2289 341.2295 1.8 ppm
10.1N C19H29OSi
+ 301.1976 301.1982 2.0 ppm
10.3N C19H20D9OSi
+ 310.2550 310.2547 1.0 ppm
10.5N C19H20D9OSi
+ 310.2552 310.2547 1.6 ppm
10.6N C19H29OSi
+ 301.1998 301.1982 5.3 ppm
10.1O C12H21OSi
+ 209.1346 209.1356 4.8 ppm
10.3O C12H12D9OSi
+ 218.1916 218.1921 2.3 ppm
10.5O C12H12D9OSi
+ 218.1922 218.1921 0.5 ppm
10.6O C12H21OSi
+ 209.1362 209.1356 2.9 ppm
10.1P C12H20OSi
•+ 208.1271 208.1278 3.4 ppm
10.3P C12H11D9OSi
•+ 217.1842 217.1843 0.5 ppm
10.5P C12H11D9OSi
•+ 217.1845 217.1843 1.0 ppm
10.6P C12H20OSi
•+ 208.1287 208.1278 4.3 ppm
11.1D C22H30D3OSi
+ 344.2472 344.2483 3.2 ppm
11.3D C22H21D12OSi
+ 353.3052 353.3048 1.1 ppm
11.5D C22H21D12OSi
+ 353.3051 353.3048 0.9 ppm
11.6D C22H30D3OSi
+ 344.2487 344.2483 1.2 ppm
13.1N C18H27OSi
+ 287.1826 287.1826 0.0 ppm
13.3N C18H18D9OSi
+ 296.2395 296.2391 1.4 ppm
13.5N C18H18D9OSi
+ 296.2395 296.2391 1.4 ppm
13.6N C18H27OSi
+ 287.1834 287.1826 2.8 ppm
13.1P C11H18OSi
•+ 194.1123 194.1121 1.0 ppm
13.3P C11H9D9OSi
•+ 203.1690 203.1686 2.0 ppm
13.5P C11H9D9OSi
•+ 203.1689 203.1686 1.5 ppm
13.6P C11H18OSi
•+ 194.1128 194.1121 3.6 ppm
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3.7.5 | m/z 301, 209 and 208
The mass spectra of the per-TMS derivatives of both 3-oxo-4-ene
steroids testosterone (10) and 16,16,17-[2H3]-testosterone (11) show
fragment ions at m/z 301.2, 209.1 and 208.1. The m/z 301.1 (10.1N,
Table 2, Table 4) ion can be explained by the loss of C-15-C-17
together with the attached O-TMS group (Table 3). For
16,16,17-[2H3]-testosterone (11) an additional fragment ion at m/z
302.2 (11.1N, Table 2) is observed which may be explained by
transfer of one of the deuterium atoms from position C-16 or C-
17 during generation of the fragment ion. Different positions of
origin for the formation are possible, due to the occurrence of
these two ions at m/z 301.2 and 302.2. In the mass spectrum of
19-nortestosterone (13.1N, Tables 2 and 4) this fragment ion is
observed at m/z 287.2 (for mass spectra, see supporting
information).
The ions at m/z 209.1 (10.1O) and 208.1 (10.1P, Tables 2 and 4)
are made up of part of the A- and B-ring16 when bonds C-9/C-10 and
C-7/C-8 are broken, which is facilitated by the Δ5 double bond
formed after enolization (10.1, Table 3). All three described A-ring
fragment ions show the respective mass shifts of +9 m/z units to m/z
310.3, m/z 218.2 and m/z 217.2 for the perdeuterotrimethylsilylated
(10.3N,O,P) and the 3-[2H9]TMS-17-TMS testosterone (10.5N,O,P,
Tables 2 and 4) and 16,16,17-[2H3]-testosterone (11.3N,O,P and
11.5N,O,P, Table 2) derivatives (for mass spectra, see supporting
information). The m/z 194.1 fragment ion is found in the mass
spectrum of 19-nortestosterone (13.1P, Tables 2 and 4) and can be
considered analogous to m/z 208.1 for testosterone (10.1P, Table 2).
3.8 | Summarizing discussion
The formation of the [M – CH3]
+, [M – TMSOH]•+ and [M – CH3-TMSOH]
+
fragment ions in hydroxy steroids was shown to be dependent on steric
factors, degree of saturation of the steroid backbone, and hydrogen
and O-TMS group availability in the 1,3-diaxial position.
Methyl radical cleavage occurs primarily from the TMS groups in
saturated androstanes 1–4, but from the steroid nucleus in the case
of androst-4-ene-3β,17β-diol (6) and oxo steroids or α,β-unsaturated
steroid ketones (8–11). Androst-5-ene-3β,17β-diol (5) and 5α-DHT (7)
cleave off methyl groups from TMS groups and C-18 or C-19 in a
ratio of approximately 50:50.
TMSOH is most abundantly eliminated from position C-17 for
5α-androstanes 1–2 and from the 3α position in 5β-androstanes 2–4.
Double bonds in positions Δ4 (6) and Δ5 (5) direct TMSOH loss to the
A-ring due to the increased stability of the resulting [M – 90]•+ ion. If an
oxo group is present in the molecule (steroids 7–11) loss of
trimethylsilanol predominates from the respective TMS ether and not
from the TMS enol function. In 16,16,17-[2H3]-testosterone all three
attached deuterium atoms were retained in the D-ring after TMSOH loss
from C-17. Similarly, all deuterium atoms in 2,2,3,4,4-[2H5]-androsterone
(8.4) were also retained, which is in line with the hypothesis of
1,3-loss.
For the formation of the [M – CH3 – TMSOH]
+ = [M – 105]+
fragment ion the required methyl radical cleavage predominates from
one of the angular methyl groups in position C-18 or C-19 and not
from the TMS methyl groups. Fragment ions [M – 90]•+ and
[M – 105]+ are generated independently from each other and can
originate from different TMS groups within the steroid backbone.
For steroids 4–7, however, both fragment ions can be traced back to
the same TMS group. Derived from 19-norandrosterone (14)
spectra, cleavage of CH3-TMSOH including the C-18 methyl group is
deduced but this needs confirmation for the other steroids
investigated.
The [M – CH3 – (CH3)2SiH-OH]
+ = [M – 15 – 76]+ fragment ion
may be explained by loss of a methyl radical from a TMS function
followed by neutral loss of the remaining dimethylsilyloxy group plus
two additional hydrogen atoms from the steroid backbone. In the case
of the 18O-labelled derivatives, losses to form both [M – 91]+ and
[M – 93]+ = [M – CH3 – (CH3)2SiH-
18OH]+ ions are observed,
showing that there is no preferred cleavage site (from C-3 or C-17).
For the different steroid subclasses, diagnostic fragment ions at
m/z 129, [M – 129]+, 127, 143, 169, 301, 209 and 208 were discussed
and proposed structures postulated: the m/z 129 ion originates from
the D-ring in the case of the androstanediols 1–4 and androst-4-ene-
3β,17β-diol (6). The Δ5 steroids androst-5-ene-3β,17β-diol (5) and
DHEA (9) generate m/z 129 from the A-ring and additionally exhibit
an [M – 129]+ ion which is formed from the remainder of the molecule
including the D-ring. The m/z 127 ion is observed in the mass spectrum
of 5α-DHT (7), derived from the A-ring, and might be analogous to m/z
129 with an additional double bond. The m/z 143 ion can be described
as a resonance-stabilized 3-(O-trimethylsilyl)but-1-ene and is attributed
to the A-ring for androst-4-ene-3β,17β-diol (6) and 5α-DHT (7). The
m/z 169 ion can be considered as a marker for 17-oxo steroids and is
thus derived from the D-ring in androsterone (8) and DHEA (9).
Fragment ions at m/z 301, 209 and 208 were observed in the mass
spectrum of testosterone (10) and 16,16,17-[2H3]-testosterone (11):
m/z 301 is produced by loss of C-15–C-17 together with the attached
OTMS group and m/z 208 and 209 are made up of part of the A- and
B-rings.
4 | CONCLUSIONS
Mass spectral fragmentation analyses showed clear correlation
between steroid structure and the obtained mass spectra. Viable and
practical approaches for the introduction of [2H9]-TMS and
18O were
developed and employed to better characterize structural features of
different steroid subclasses in GC/EI-MS spectra. The World Anti-
Doping Agency requires both the retention time and unambiguous
mass spectrometric characteristics for confirming the identity of
compounds by means of GC/MS.38 The discussed stable isotope
labelling procedures are suitable tools to achieve this confidence in
mass spectral findings due to the respective mass shifts of +9 m/z
units for [2H9]-TMS groups and +2 m/z units for oxygen-18 even
when using unit mass resolution GC/MS alone. Additional GC/QTOF
KOLLMEIER AND PARR 19 of 21
accurate mass spectra substantiated the elemental compositions of
some diagnostic fragment ions but were not mandatory to explain the
origin of the ions. In the case of isomer assignments this approach
may be more suitable.
Both stable isotope labelling methods enable the detection of
structure-related fragment generation in GC/EI-MS which may in turn
allow us to propose isomeric assignments that are otherwise almost
impossible using MS only. Based on these findings, a considerable
reduction in the number of reference isomers needed for proper
identification (generally including additional retention time
comparison) of unknowns is possible.
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